Renhuang Pharmaceuticals, Inc. reported that it has successfully produced lyophilized syringin powder, a new form of a successful traditional Chinese medication. The substance is a powder injection intended to treat depression and fatigue. It is extracted from Acanthopanax (also known as Siberian Ginseng), a product that already supplies 53% of Renhuang’s revenues. Renhuang intends to put the substance into clinical trials to prove safety and efficacy. More details... 

Stock Symbol: (OTCBB: RHGP)